Diagnosis of early gastric cancer

Research output: Patent


The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.
Original languageEnglish
Publication Year9 Jul 2002
Publication statusPublished - 9 Jul 2002
MoE publication typeH1 Granted patent

Fields of Science

  • 312 Clinical medicine

Cite this

Ristimäki, A., Harkonen, M., & Sipponen, P. I. (2002). IPC No. C12Q 1/68 (20060101). Diagnosis of early gastric cancer. (Patent No. US patent 6,416,961).